Chapman University School of Pharmacy (CUSP) Market Research Report

Background

Overview

Chapman University School of Pharmacy (CUSP), located at the Rinker Health Science Campus in Irvine, California, is a prominent institution dedicated to advancing pharmaceutical education and research. Established to meet the evolving needs of the healthcare sector, CUSP offers a range of programs designed to cultivate the next generation of pharmacists and pharmaceutical scientists.

Mission and Vision

CUSP's mission is to educate and promote diversity in the next generation of pharmacists and pharmaceutical scientists to improve health through engaging in inclusive and equitable team-based, patient safety-focused healthcare and conducting transformative research and scholarship. The vision is to empower students to become self-learning professionals through innovative teaching methods, provide an infrastructure that emphasizes collaborative research, and create a diverse and inclusive culture that supports the success of students, faculty, and staff.

Primary Area of Focus

CUSP focuses on delivering an accelerated Doctor of Pharmacy (Pharm.D.) program, along with Master of Science (MS) and Doctor of Philosophy (Ph.D.) degrees in pharmaceutical sciences. The institution emphasizes personalized education, innovative research, and experiential learning to prepare students for diverse careers in the pharmaceutical industry, academia, and healthcare settings.

Industry Significance

As an R2 institution, CUSP contributes significantly to the pharmaceutical sciences through its research initiatives, faculty expertise, and community engagement. The school's strategic location in Southern California positions it at the nexus of biomedical, biotech, and pharmaceutical industries, enhancing its impact on healthcare delivery and pharmaceutical advancements.

Key Strategic Focus

Core Objectives

Accelerated Education: Offer an accelerated Pharm.D. program that enables students to earn their degree in less than three years.

Research Excellence: Foster a strong research foundation with faculty possessing diverse expertise to advance pharmaceutical sciences.

Community Engagement: Strengthen community partnerships to optimize healthcare delivery for diverse and underserved populations.

Specific Areas of Specialization

Pharmaceutical Sciences: Focus on drug design, discovery, and development.

Clinical Pharmacy: Emphasize patient care, medication therapy management, and health outcomes.

Regulatory Affairs: Prepare students for navigating the global regulatory landscape in pharmaceutical development.

Key Technologies Utilized

Flipped Learning Pedagogy: Leverage state-of-the-art technology to enhance student learning experiences.

Interdisciplinary Collaboration Tools: Utilize platforms that facilitate teamwork among students and faculty across various health disciplines.

Primary Markets or Conditions Targeted

Pharmaceutical Industry: Prepare students for roles in drug development, regulatory affairs, and industry research.

Healthcare Systems: Equip students to improve patient care and medication management within diverse healthcare settings.

Academic Institutions: Train future educators and researchers in pharmaceutical sciences.

Financials and Funding

Funding History

As an academic institution, CUSP's funding primarily comes from tuition, research grants, and philanthropic contributions. Specific financial details are not publicly disclosed.

Total Funds Raised

While exact figures are not publicly available, CUSP has secured significant research funding from federal, college, not-for-profit, and industry sources to support its initiatives in pharmaceutical sciences.

Notable Investors

CUSP collaborates with various industry partners, including AJK Biopharmaceutical, Merck, Masimo, Cornerstone, Zymo, Amberstone, Dxome, and Paratek Pharmaceuticals, to advance research and educational programs.

Intended Utilization of Capital

Research Initiatives: Support faculty-led studies in areas such as neurological disorders, drug discovery, and health technology.

Educational Programs: Enhance curriculum development, experiential learning opportunities, and student support services.

Infrastructure Development: Expand and upgrade facilities to provide state-of-the-art learning environments.

Pipeline Development

Key Pipeline Candidates

CUSP's research focuses on several key areas:

Neurological Disorders: Investigating treatments for conditions like hypothyroidism and cardiovascular diseases.

Cancer Research: Developing next-generation peptide-drug conjugates for melanoma treatment.

Health Technology: Advancing ethical applications of artificial intelligence in healthcare.

Stages of Clinical Trials or Product Development

Specific details on clinical trial stages are not publicly disclosed. However, CUSP's faculty have received significant research grants to support ongoing studies in these areas.

Target Conditions

Hypothyroidism: Research led by Dr. Cintia Citterio focuses on unraveling mechanisms underlying this condition.

Melanoma: Dr. Sun "Coco" Yang's work aims to advance care for this aggressive form of skin cancer.

Cardiovascular Diseases: Innovative approaches are being developed to protect aging hearts.

Relevant Timelines for Anticipated Milestones

While specific timelines are not publicly available, CUSP's faculty have been awarded substantial grants, indicating ongoing and future milestones in their research endeavors.

Technological Platform and Innovation

Proprietary Technologies

CUSP employs innovative teaching methods, including flipped learning pedagogy, to enhance student engagement and learning outcomes.

Significant Scientific Methods

Flipped Learning Pedagogy: An instructional strategy that inverts traditional teaching methods, promoting active learning and student engagement.

Interdisciplinary Collaboration: Facilitated through advanced communication platforms, enabling teamwork among students and faculty across various health disciplines.

AI-Driven Capabilities

Faculty member Dr. Sherry Wang has been recognized for her leadership in ethical healthcare AI, highlighting CUSP's commitment to integrating advanced technologies in research and education.

Leadership Team

Key Executive Profiles

Dr. Rennolds Ostrom: Dean of CUSP, Dr. Ostrom has been instrumental in the school's growth, focusing on research, education, and expanding influence over Orange County's healthcare systems.

Dr. Lawrence "LB" Brown: Associate Dean of Undergraduate Pharmacy Programs and Partnerships, Dr. Brown oversees the Accelerated Pre-Pharmacy Experience Program, providing guidance and support to students.

Dr. Sherry Wang: Recognized as the AI Researcher of the Year by Women in AI, Dr. Wang leads research in ethical healthcare AI applications.

Leadership Changes

In January 2026, Dr. Ashley Daffron rejoined Chapman University as an Associate Professor of Pharmacy Practice, bringing additional experience from her tenure at the University of Colorado.

Competitor Profile

Market Insights and Dynamics

The pharmaceutical education sector is characterized by a growing demand for healthcare professionals, driven by an aging population and increasing healthcare needs. Institutions like CUSP play a crucial role in addressing this demand through innovative education and research.

Competitor Analysis

CUSP's primary competitors include other pharmacy schools in California, such as the University of Southern California (USC) School of Pharmacy, University of California, San Francisco (UCSF) School of Pharmacy, and University of California, Los Angeles (UCLA) School of Pharmacy. These institutions offer similar programs and have established reputations in the field.

Strategic Collaborations and Partnerships

CUSP has formed strategic partnerships to enhance its educational offerings and research capabilities:

Charles R. Drew University of Medicine and Science: In January 2025, CUSP and CDU announced a partnership to provide new pathways for CDU students to pursue graduate pharmacy degrees, including guaranteed application interviews and scholarships.

Operational Insights

CUSP differentiates itself through its accelerated Pharm.D. program, allowing students to earn their degree in less than three years. The institution's focus on personalized education, innovative research, and community engagement positions it competitively within the market.